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SUMMARY 
• Aromatase cytochrome P450 enzyme catalyzes the for- 
mation ofestrogenfrom androgen in distinct regions of the ver- 
tebrate brain. During neural development, local estrogen syn- 
thesis is required for the sexual differentiation of male brain 
characteristics and the differentiation of neural circuits In- 
volved in sex-specific behaviors and neuro endocrine functions. 
A common phenomenon in all species studied so far is that the 
male brain displays much higher and. brain region-specific 
aromatase expression during distinct periods of brain devel- 
opment than the female one. An important question arising from 
these findings is which factor(s) play a role in regulating es- 
trogen formation in a sex- and brain region-specific fashion. 
Among the factors investigated, androgens have been found 
to be the most powerful regulators of brain aromatase. In vitro 
experiments using primary cell cultures of embryonic mouse 
brains showed that sex differences in aromatase activity in hy- 
pothalamic cells develop, at first, independently of gonadal 
steroids. Later during embryonic development, aromatase ex- 
pression is regulated in a region- and sex-specific way by cir- 
culating androgens. Hypothalamic aromatase neurons are 
inost sensitive to androgen exposure whereas cortical and mid- 
bnlin,(> H'x  are insensitive. Moreover, androgens affect mor- 
pliolt\\!*col. maturation ofaromatase-immunoreactive cells by 
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stimulating neurite outgrowth and dendritic arborization. 
These findings suggest that androgens function as major rnor- 
phogenetic factors during the differentiation of the mamma- 
lian hypothalamic aromatase system. During late embryonic 
development and perinatally, androgen levels differ between 
sexes, being significantly higher in males. This time period 
corresponds exactly to the developmental stage when aroma- 
tase activities are highest in the male hypothalamus. It seems 
plausible therefore that higher androgen concentrations in the 
male circulation during ontogenesis are causally connected 
with the observed sex differences in hypothalamic aromatase 
activity. (Biomed Rev 1997; 7: 41-50) 
INTRODUCTION 
• Structural and functional sex differences in the vertebrate 
central nervous system (CNS) have been described at almost 
every level (reviewed in 1). Although the way in which brain 
morphological dimorphisms between sexes contribute to func- 
tional sex differences is not well understood, sex-specific be- 
haviors and centrally regulated processes are generally believed 
to rely on such structural differences (2, 3). Sex differences in 
the adult CNS are generally confined in terms of volumes of brain 
nuclei to differences in cell numbers/densities and synaptic 
morphology (3-6). Most, but not all, sexually differentiated nu- 
clei of the mammalian hypothalamus are larger and contain more 
-cells in males than in females (7-12). It has to be noted, how- 
ever, that sex differences are not restricted to the hypothala- 
mus. A number of recent investigations have demonstrated 
sexually dimorphic structures and functions in almost all brain 
regions such as the striatum, cortex, and hindbrain (1, 13-16). 
  
  
An important question which has been intensively studied over 
the last lour decades concerns the developmental processes 
which are responsible for a sexually dimorphic organization of 
CNS structures. As early as 1959, Phoenix and collaborators (17) 
published a fundamental study on the effects of gonadal ste- 
roid hormones during perinatal development on sexual behav- 
ior in guinea pigs. It was suggested that gonadal steroids may 
cause a sex-specific organization of the male CNS during acriti- 
cal perinatal period of development. Later on it was demon- 
strated that the testosterone metabolite 17B-estradiol was in- 
deed the biologically active compound controlling sexually di- 
morphic development ol the male brain (18,19). Direct evidence 
lor the aromatization of androgens to estrogens by central neu- 
ral tissues was provided by Naftolin c^o/ (20). These findings 
led to the ,,aromatization hypothesis" postulating that andro- 
gen effects on the differentiation of male-specific brain circuit- 
ries and functions in vertebrates are actually mediated by es- 
trogens formed locally in discrete brain areas from androgens 
by the enzyme aromatase. The aromatase is an enzyme complex 
comprised of a specific form of microsomalcytochromeP450 and 
the flavoprotein NADPH-cytochrome P450 reductase (mixed 
function oxidase) and catalyzes the conversion of testosterone 
into 17B-estradiol (21). Studies of the avian aromatase system 
have contributed to an understanding of how this enzyme sys- 
tem develops in relation to a complex sexually dimorphic motor 
pattern - song. One of the most interesting models is the Zebra 
finch, in which there is a sexual dimorphism in the size of brain 
nuclei controlling song. In males, both the volume and cell size 
of motor nuclei, and higher forcbrain nuclei involved in the con- 
trol of song, are larger than those in females (25). The develop- 
ment of the song control system depends in part on estrogens 
acting on the brain in post-hatching development (25). The 
source of estrogen is still unclear. However, sex-specific circu- 
lating levels of estrogen (higher levels in the male) may be due 
(o extremely high rates of aromati/.ation in the telencephalon at 
post-hatching periods of development (26,27). . 
Over the years, a considerable number of investigations have 
now confirmed that perinatal estrogen exposure of the CNS per- 
manently changes neuronal/glial morphology and brain func- 
tions in males (reviewed in 2, 22-24).The sexually dimorphic 
nucleus of the medial prcoptic area (SDN-POA) is probably one 
of the best studied sexual dimorphic structures of the mamma- 
lian brain. Originally described in Nissl-stained frontal sections 
of the rat dicncephalon, this cytoarchitechtonically heteroge- 
neous nucleus was found to be five to eight times larger in male 
than in female rats (9). Subsequent developmental studies re- 
vealed that the differentiation of this nucleus depended on a 
massive increase in volume in the male due to higher neuronal 
numbers which did not occur in the female (29,30). Interestingly, 
sex differences in the SDN-POA are already apparent by post- 
natal day 2 (29, 30). Prom these and other studies it was con- 
cluded that the ontogeny of sex differences in the vertebrate 
brain takes place during a limited critical period of neural devel- 
opment during late embryonic stages and the first postnatal 
days (31). Later on, the establishment of the SDN-POA was 
clearly shown to depend on the perinatal steroid hormone milieu 
(31,32), and it has been demonstrated that the development of 
the SDN-POA requires the aromatization of androgens, i.e. is 
mediated by estrogens (33,34). Itis now generally accepted that 
estrogens formed within the brain play a decisive role for the de- 
velopment of most of the sex-specific characteristics in the CNS 
so far described, and that these sexual dimorphisms become es- 
tablished during a hormone-sensitive critical period of develop- 
ment, usually around birth (2,4,6,22). As shown above for the 
differentiation of the SDN-POA, estrogens arc capable first af- 
fecting the neuromorphology by directly regulating cell prolif- 
eration and/or cell death. Besides determining the fate of neu- 
rons/glial cells, estrogens also modulate functional (35) and 
neuromorphological properties, such as cell size (33), synapse 
formation (37-39), axon outgrowth (40, 41), and dendritic ar- 
borization (41,42). Finally, it is believed that developmental es- 
trogen effects at the cellular level represent the basis for sexual 
dimorphisms in brain circuitries responsible for sex-specific 
behaviors and neuroendocrine functions (2, 3, 28). Notwith- 
standing the importance of the epigenetic action of estrogens for 
the generation of sexual dimorphic brain structures and func- 
tions as shown above, there is, in addition, emerging evidence 
that genetic factors, probably coded by Y-chromosomal genes, 
are involved in the process of sexual differentiation of the CNS 
(1,3,10-12,24,43-45). It might be concluded that sexual differ- 
entiation of the brain requires not only epigenetic, hormone- 
dependent mechanisms but also the brain-intrinsic realization of 
the genetic program in particular neuronal populations. 
Although the role of estrogens formed in distinct brain areas for 
the process of sex-specific neuronal development in vertebrates 
is intensively studied and reviewed by several authors in the past 
(22,46-48), little is known about the regulation of the key enzyme 
in estrogen synthesis, the aromatase, during embryonic and early 
postnatal development in male and female CNS. In this review we 
will focus on developmental aspects of the regulation of brain 
aromatase expression and activity in the rodent and avian brain. 
Thisreviewwill, where appropriate, go into the particulars of the 
regulation of aromatase in the adult brain. Finally, recent stud- 
ies will be presented which have utilized molecular biology tech- 
niques to investigate brain aromatase.  
DISTRIBUTION AND DEVELOPMENTAL 
PROFILE OF BRAIN AROMATABE 
M Aromatase enzyme activity has been detected in several 
limbic brain tissues of all vertebrate species studied so far (49, 
50). Indirect (51,52) as well as direct (53) evidence clearly sug- 
gests the aromatase is a neuron-specific enzyme in the rodent 
CNS, whereas in the avian brain, residual aromatase activity has   
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also been reported for glial cells (54). Using aromatase-specific 
antisera and immunocytochemical staining techniques, analy- 
sis of the subcellular distribution of aromatase revealed that this 
enzyme is confined to the cell so ma as well as to axons, den- 
drites, synaptic boutons (55, 56) and even growth cone-like 
structures (57). These immunohistochemical findings are in 
agreement with the previous demonstration of aromatase activ- 
ity in synaptosomal and microsomal preparations (58,59). 
Aromatase activity and aromatasc-immunoreactive nerve cells 
arc not uniformly distributed throughout the brain but rather 
arc highly concentrated in discrete limbic and hypothalamic 
ureas (52, 60-62) whereas only low to moderate levels of aro- 
matase activity can be detected in several other brain regions, 
such as cortical areas, the hippocampus, the pituitary, and the 
midbrain (52,53,63-66). Generally, immunocytochemical undm 
.\Vf(( hybridization or poly merase chain reaction studies (65,67- 
f)9) of the aromatase and the aromatase mRNA, respectively, 
have confined the distribution and localization of aromatase to 
CNS structures where aromatase activity has been previously 
detected. Highest brain aromatase levels in adults are found in 
dicncephalic structures such as the bed nucleus of .s'fna f<?/'- 
mmo/As- (BNST) and the medial preoptic nucleus as well as in 
the medial and cortical amygdala compared to intermediate lev- 
els which have been measured in the anterior hypothalamus and 
the ventromedial nucleus (62)  
Consistent with its important role for the sexual differentiation 
of reproductive brain functions, levels of hypothalamic 
uromatase activity are significantly greater during the perina- 
tal period in rodents than at any subsequent age. Hypothalamic 
aromatase activity rises rapidly before birth in rodents (mouse, 
rat), followed by a sharp decrease during the initial postnatal 
period (52, 69-71). This is in agreement with findings which 
demonstrate peak levels in hypothalamic aromatase mRNA 
expression at this developmental stage in the mouse and rat (69- 
72). In addition, immunocytochemical screening for aromatase- 
containing neurons during the development of the rat brain 
revealed that these cells can be first detected in the preoptic 
area on the 13th day of gestation, followed later on from day 
15th onwards in the BNST and amygdala. As gestation prog- 
resses, the number of aromatase-positive neurons and staining 
intensity for aromatase in the diencephalon gradually increases 
and peaks around birth (73). During early postnatal develop- 
ment, hypothalamic aromatase decreases to lower levels until 
the onset of sexual maturation when a further decline in enzyme 
activity can be observed (47,74,75). An important outcome of 
studying developmental characteristics of hypothalamic 
aromatase is the finding that a highly significant sex difference 
in aromatase activity levels exists throughout development. In 
general, males show higher enzyme activities than females (47, 
62, 63, 70, 75), and more aromatase-immunoreactive cells are 
found in males (52,53,76). The existence of a sexual dimorphism 
in estrogen synthesis within the hypothalamus and preoptic 
region during perinatal development is regarded as the basis 
for the sexual differentiation of male brain structures associated 
with reproductive functions (4,25,28,91). 
In addition, there is evidence that an developmental profile of 
aromatase expression, as described above for the hypothalamus, 
may also exist in the rat midbrain. The major difference be- 
tween the both brain regions is that, in the midbrain, aromatase 
expression (enzyme activity and levels of aromatase mRNA) 
is low around birth and shows a distinct peak postnatally be- 
tween postnatal day 2 and 10 (65). In contrast to the hypothala- 
mus, sex differences were not observed in the developing mid- 
brain. An important question arising from the sex- and brain 
region-specific expression of aromatase concerns which devel- 
opmental factors arc involved in regulating this ontogenetic 
profile of brain estrogen synthesis in males and females. 
DBVELOPMENTAL REGULATION OF BRAIN 
AROMATA9B 
M Although brain aromatase has been investigated for more 
than two decades, little is known about the regulation of estro- 
gen synthesis, in particular in the developing brain. Despite the 
fact that the regulation of neural aromatase is still a matter of 
controversy, this section will focus on the characterization of 
the effects of steroid hormones, neurotransmitters, and other 
biologically active compounds on brain aromatase activity/ex- 
pression during perinatal development. 
As shown in the previous section, hypothalamic aromatase ac- 
tivity in the mouse displays a clear-cut developmental profile 
and highest activity levels just before and around birth. Dur- 
ing this period, sex differences in estrogen synthesis capacity 
are most significant. However, it has to be mentioned that early 
sex differences in aromatase activity and in numbers of 
aromatase-immunoreactive cells appear to be already mani- 
fested at embryonic day 13 (53, 91). These data imply that hy- 
pothalamic aromatase is highly regulated during late embry- 
onic brain development and leads to the following questions: 
(;) What does the enzyme and is the regulation sex-specific?, 
and (;V) Is aromatase regulation phasic and do sensitive regula- 
tory periods differ between sexes? A number of studies have 
demonstrated that the classical neurotransmitter norepineph- 
rine and the B-adrenergic agonist isoproterenol inhibit neural 
aromatase in rat tissue and cell cultures (77,78). Moreover, fac- 
tors known to stimulate the formation of cAMP have been shown 
to be potent inhibitors of aromatase activity (77). These find- 
ings contrast with another study using cultured turtle brain cells 
which has found that dihutyryl cAMP enhances enzyme activ- 
ity (79). Similarly, cAMP appears to increase aromatase activity 
in cxtragonadal and gonadal tissues (80, 81). Taken these data, 
it appears that adrenergic regulation of aromatase is different in   
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neuronal and non-neuronal cells and between species, and it is 
likely that adrenergic neurotransmission coupled to the cAMP- 
dependcnt inlracellular signal transduclion pathway plays to 
some extent a role in the short-term regulation of aromatase 
activity, possibly by enzyme phosphorylation. This regulatory 
pathway cannot, however, explain neither long-lasting changes 
in aromatase expression, i.e. the developmental profile, nor the 
observed sex differences, since a higher activity of noradrener- 
gic systems located in the locus coeruleus and projecting to the 
hypothalamus is generally associated with the male sex (re- 
viewed in 82). It might be assumed that the adrenergic input for 
the hypothalamic aromatase system reflects rather a short-term 
modulatory than a long-term regulatory mechanism. Other fac- 
tors tested for their ability to change hypothalamic aromatase 
activity such as fibroblast growth factors, epidermal growth 
factor, and insulin-like growth factors, were ineffective (77). In 
comparison to these in vitro data, in vivo studies have shown 
thai prenatal stvess, alcohol and nicotine exposure affect brain 
aromatase. Fetuses of stressed mothers displayed reduced 
aromatase activities in both sexes (83), ethanol exposure in- 
creased enzyme activity in males only (84), and nicotine treat- 
ment abolished sex differences in hypothalamic aromatase (85). 
In conclusion, these in vitro and in vivo studies give some in- 
sights in the regulation of perinatal hypothalamic aromatase but 
are not sufficient to answer the questions raised at the begin- 
ning of this section. In particular, the complex regulation of a 
transient developmental and sex-specific profile of aromatase 
expression cannot be explained by the above factors. ;,«;' 
The failure to find clear-cut regulatory factors, drew the atten- 
tion of several research groups to gonadal steroids as potential 
aromatase regulators. In particular, androgens secreted by the 
fetal testes fullfill several criteria to be regarded as aromatase 
regulators during development: (/) the onset and profile of an- 
drogen synthesis and secretion into the systemic circulation 
coincides exactly with the profile of hypothalamic aromatase 
expression (86, 87), (/;') there are sex differences in androgen 
plasma concentrations during late embryonic and early post- 
natal development (86, 87), and (Hi) embryonic hypothalamic, 
bul not cortical aromatase-immunoreactive neurons coexpress 
androgen receptors (57). For the first time in 1981, we reported 
thai androgens induce aromatase in the adult avian brain (88). 
In the following years, we have shown that, in addition, em- 
bryonic avian aromatase is positively regulated by androgens 
(89). These studies led to the hypothesis that androgens are not 
only the substrate lor ihe aromatase bul also function as im- 
portant regulatory compounds for the developing and adult 
avian brain aromatase system (90, 91). At about the same time, 
it has been demonstrated that androgens also regulate hypo- 
Ihalamic aromatase through a receptor mechanism in the adult 
rat (47, 92) and in other mammalian species (93), and thai andro- 
gen ic stimulation of aromatase activity is due to an transcrip- 
lional induclion of aromalase mRNA expression in the hypo- 
thalamus (94-96). Mosl surprisingly, subsequent studies on the 
androgenic regulation of neural aromatase in the developing 
mammalian brain failed to demonslrate an unambiguous role for 
androgens. Castration of fetal monkeys, for example, had no ef- 
fect on hypothalamic aromatase (97), androgens either stimu- 
lated aromatase in transplants of fetal rat hypothalamic tissue 
(98) and in embryonic ferret diencephalic nuclei (99), decreased 
aromatase in cultured rat neural tissue (77), or had no effect on 
aromatase in rat hypothalamic explants (77). In order to reexam- 
ine the influence of androgens on developing hypothalamic 
aromatase nerve cells more systematically as well as to focus in 
these studies on the cellular level, we studied the effects of tes- 
tosterone on aromatase activity/expression in mouse brain cell 
cultures (hypothalamus, cortex) prepared from different embry- 
onic stages. Moreover, these primary cultures were raised in a 
sex-specific way, since we determined the sex of the embryonic 
donor by inspection of the gonadal anlage prior to cultivation 
of cells (15), By this experimeatal strategy, we were able to study 
the influence of androgens and other factors on embryonic 
aromatase at different developmental stages, in different brain 
regions, in a sex-specific way, and at ihe cellular level. Our stud- 
ies revealed that androgens stimulate aromalase aclivity in hy- 
pothalamic, but not cortical, cultures of both sexes prepared from 
embryonic day 15 mouse feluses (100). This effect was dose- 
dependent and mediated through androgen-receptor activation, 
since it was completely blocked by the androgen receptor an- 
tagonist flu tarn ide. Further analysis of androgen effects have 
shown that the stimulation of aromatase activity results from 
an increase in the number of neurons expressing aromatase (100) 
and aromatase mRNA (Beyer, unpublished observalion), and 
from an increased aromatase expression per aromatase-immu- 
noreactive cell (100). Interestingly, androgens were only effec- 
tive during a short developmental window. When cultures were 
prepared from fetuses on embryonic day 13 or 17, no such an 
androgen effect was observed (48, 101). These dala strongly 
imply that aromatase neurons become sensitive to circulating 
androgens only during a distincl time-window of embryonic de- 
velopment. It remains, however, still unclear which factors de- 
termine this sensitivity. At least, the expression of androgen 
receptors by aromatase-immunoreactive neurons, or by cells 
which become aromatase-posilive later during developmenl after 
androgen stimulation, seems to be a decisive event. From these 
findings we conclude that the failure of previous studies to find 
a clear-cut role of androgens in developmental regulation of 
brain aromatase might result from the fact thai Ihe lissues and 
cell cultures used for these experimenls did nol match the ap- 
propriate sensitive period for aromatase induction, and thai none 
of the sludies listed above used sexed embryos for their cultur- 
ing experiments (77,97). In addition to the functional regulation 
of hypothalamic aromatase, our studies further revealed that 
androgens also regulate the morphological maturation of hy- 
pothalamic aromatase cells. Thus, androgen treatment of cell 
cultures grown in steroid-free synthetic medium stimulates 
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neurile outgrowth and branching in aromatase neurons; again, 
these morphogenetic effects depend on androgen receptor ac- 
t ivation and are restricted to hypothalamic, but not cortical 
aromatase cells (57). Taken together, our data clearly demon- 
strate that androgens function as morphogenetic signals for 
developing hypothalamic aromatase neurons, thereby being 
potentially effective in influencing the activity, plasticity, and 
synaptic connectivity of hypothalamic aromatase systems (48, 
101,102). 
Our data further suggest that the sex-specific development of 
hypothalamic aromatase neurons is likely to result from dif- 
ferences in androgen concentration, since testosterone levels 
during this androgen-sensitive embryonic developmental stage 
arc higher in males compared to females (86, 87). However, 
sex differences in androgen levels do not appear to be the only 
factor responsible for sexual dimorphisms of the hypothalamic 
aromatase system. First, aromatase activity and the number of 
uromatase-positive neurons are higher in males well before the 
onset of androgen synthesis by the fetal testis (52, 53, 100). This 
strongly implies that sexual differentiation of the hypothalamic 
aromatase system develops originally independent of gonadal 
steroids. Second, sex differences of the hypothalamic aromatase 
system also appear to be further affected and possibly stabilized 
by androgens and differences in androgen-responsiveness be- 
tween sexes during late embryonic development (103, 104). 
Third, there is emerging evidence that sex differences in the 
mammalian brain involve the sex-specific realization of a cell- 
intrinsic genetic program (3, 10-12, 15, 24). One candidate 
gene that might be reponsible for generating male-specific 
properties of neural cells is the Y-chromosomal gene and tes- 
lis-determining factor, Sry (105, 106). Recent evidence sug- 
gests that Sry, a putative transcriptional activator with a DNA- 
binding domain, is expressed in mouse brain (107) and is ca- 
pable of binding to DNA sequences in the promoter region of 
the gene encoding aromatase (108). Further studies of the ge- 
nomic control of aromatase expression in male and female 
developing hypothalamus are required that will permit the 
molecular basis of this complex developmental pattern of sex- 
specific aromatase expression to be elucidated. 
CONCLUSION 
• Estrogen formation from androgens is catalyzed by the 
aromatase, a neuronal enzyme. This enzyme plays a crucial role 
in the sexual differentiation of the male brain in mammals during 
prc- and early postnatal periods of development. Regulation of 
the brain aromatase is an important step in determining when 
estrogen is available to act on the differentiating neural cells. 
Hypothalamic aromatase expression in rodents is characterized 
by a precisely delimited ontogenetic profile with peak levels of 
estrogen synthesis just before and around birth. During this time 
span, males display significantly higher aromatase activities 
compared to females. Several lines of evidence suggest that 
hypothalamic aromatase expression is highly regulated perinatally. 
Besides the influence of classical neurotransmitters such as 
norepinephrine on the catalytic activity of the enzyme, andro- 
gens appear to be the major regulatory factors for the develop- 
ing hypothalamic aromatase system. Thus, androgens target the 
functional status of aromatase neurons by regulating the expres- 
sion of the enzyme. By stimulating the morphological matura- 
tion of aromatase cells, the androgenic environment of the hy- 
pothalamus also appears to be instrumental in determining sex 
differences in a network of aromatase-immunoreactive nerve 
cells which provide estrogen required for the differentiation of 
male brain structures. 
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